Should Lantus Be Continued This Morning While NPO?
Yes, continue Lantus this morning at a reduced dose of 60-80% (approximately 4-6 units) of the usual 7 units while the patient remains NPO, and monitor blood glucose every 4-6 hours with correction insulin available.
Rationale for Dose Reduction
The most recent and authoritative guideline from the American Diabetes Association 1 specifically addresses this scenario for perioperative/NPO management. The guideline recommends giving 60-80% of the usual long-acting basal insulin analog dose when patients are NPO for procedures or surgery. This approach maintains basal insulin coverage to prevent hyperglycemia while reducing hypoglycemia risk.
For your patient on 7 units:
- 60% dose = 4 units
- 80% dose = 6 units
- Recommended range: 4-6 units
Why Continue Basal Insulin While NPO?
Long-acting basal insulin analogs like Lantus (insulin glargine) provide continuous background insulin that:
- Suppresses hepatic glucose production
- Prevents diabetic ketoacidosis (especially critical in type 1 diabetes)
- Maintains metabolic stability even without food intake
The Endocrine Society guideline 2 provides compelling evidence that full doses of basal insulin can be safely administered when patients are NPO, particularly citing a study where type 1 diabetes patients received their full glargine dose on fasting days with no significant difference in mean blood glucose compared to eating days. However, for well-controlled patients, a 10-20% reduction is suggested, and for those on NPH insulin, a 25-50% reduction is recommended.
Critical Monitoring Requirements
While NPO, implement the following protocol 1:
- Monitor blood glucose every 4-6 hours minimum
- Administer short- or rapid-acting insulin for correction if blood glucose exceeds 150-180 mg/dL
- Target range: 80-180 mg/dL (perioperative guideline standard)
- Treat hypoglycemia immediately if blood glucose falls below 70 mg/dL
Type of Diabetes Matters
The recommendation differs slightly based on diabetes type:
Type 1 Diabetes 2:
- Well-controlled patients: 10-20% dose reduction (5-6 units)
- Poorly controlled (glucose >200 mg/dL): Can give full dose (7 units)
- Never withhold basal insulin - risk of diabetic ketoacidosis
- Standard 60-80% dose reduction (4-6 units)
- Well-controlled on diet alone may need minimal insulin
- More flexibility in dosing adjustments
Common Pitfalls to Avoid
Never completely withhold basal insulin - This is the most dangerous error, particularly in type 1 diabetes where it can precipitate diabetic ketoacidosis within hours
Don't confuse basal with prandial insulin - Prandial (mealtime) insulin should be held while NPO, but basal insulin serves a different physiologic purpose
Avoid using only sliding scale/correction insulin - This reactive approach without basal coverage leads to poor glycemic control and increased complications 1, 2
Don't forget to restart full dosing - Once the patient resumes eating, return to the usual 7-unit dose
Timing Considerations
The FDA label for Lantus 3 indicates it can be administered at any time of day, but should be given at the same time daily. If the patient usually takes Lantus in the morning, continue morning administration. The 24-hour duration of action means the timing itself is less critical than consistency and appropriate dose adjustment for NPO status.
When NPO Status Ends
Once oral intake resumes:
- Return to the usual 7-unit dose
- Resume prandial insulin with meals
- Continue monitoring for 24-48 hours to ensure stability